Navigation Links
Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting

active-transport peptides derived from phage libraries. The abstracts are available and can be viewed on-line at no charge through the AACR website at http://www.aacr.org, which is not part of this press release.

About Antigen-Binding peptides or Abtides(TM)

AxCell has developed Abtides; small, highly specific peptides, 38-43 amino acids in length, obtained from its novel phage libraries. Their small size, specific target recognition, high affinity and cost-efficient one-step chemical synthesis make them ideal as therapeutic and/or imaging agents and provide valuable advantages over other targeting agents, such as monoclonal antibodies. AxCell has already produced Abtides that target prostate-specific membrane antigen (PSMA) on prostate cancer cells and MUC-1, a tumor antigen expressed in breast, pancreatic and ovarian cancers. Other Abtides with specificity for EGFR-positive tumors are also being investigated.

About Oral Drug Delivery Technology

AxCell has also developed oral drug delivery agents - random peptide compositions that bind to gastro-intestinal tract (GIT) transporter proteins. These oral delivery agents are capable of facilitating transport of an active agent from the lumenal side of the GIT into the systemic blood system, and/or in targeting active agents to the GIT. By binding (covalently or noncovalently) these oral delivery agents to a drug or by coating the surface of nanoparticles or liposomes with these delivery agents, drugs can be targeted to specific receptor sites or transport pathways known to operate in the human gastrointestinal tract, thus facilitating its systemic absorption into the bloodstream. The binding of these oral delivery agents to GIT receptors has been confirmed in preclinical models, and successful in vivo delivery of nanoparticle-encapsulated insulin and leuprolide in animal models has been demonstrated.

About Cytogen

Cyto
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
8. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
11. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
Post Your Comments:
(Date:12/17/2014)... YORK , Dec. 17, 2014 ... imaging (MRI), the MRI market is seeing new ... and breast MRI scans account for the majority ... a higher resolution of images, which are creating opportunities ... imaging (MRI) market is growing at a rate ...
(Date:12/17/2014)... -- , The new Dompé ... information concerning the biopharmaceutical Group,s national and international clinical research ... the recently launched institutional website that is receiving accolades from ... a new chapter in the fascinating story of Drug Discovery ... panoramic hub on the world of clinical research, ranging from ...
(Date:12/17/2014)... BUENA, N.J. , Dec. 17, 2014  IGI ... announced today the closing of its offering of $125 ... due 2019 (the "Notes").  The Notes were offered and ... 144A under the Securities Act of 1933, as amended ... at a fixed rate of 3.75% per year, payable ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... , Rochester Medical Corporation (Nasdaq: ROCM ) will ... 2009. The Company will then hold a quarterly conference call ... 3:30 p.m. central time (4:30 p.m. eastern time). , This call ... Medical,s website at www.rocm.com . To listen ...
... Oct. 28 Qualsec (OTC Bulletin Board: QLSZ), which recently ... has been elected as a member of the Board of ... of clinical experience followed by 6 years of medical device ... and only FDA cleared RFID medical information device of its ...
Cached Medicine Technology:Rochester Medical Announces Fourth Quarter 2009 Earnings Conference Call Thursday, November 5th 2009 2VitaminSpice Appoints Dr. Richard F. Seelig as Director 2
(Date:12/17/2014)... HealthDay Reporter TUESDAY, Dec. ... fast approaching, a new study reveals that states that routinely ... drunk drivers on their roads. The finding suggests that ... able to deter inebriated revelers from getting behind the wheel ... being passed regarding drinking and driving," said study lead author ...
(Date:12/15/2014)... Cancer researchers have just published an ... of deadly malignant pleural mesothelioma. Surviving Mesothelioma has just ... Click here to read it now. , ... Center, and New York’s Langone Medical Center performed complete ... in an effort to pinpoint the genes that ...
(Date:12/15/2014)... SIMpalm, a leading mobile app development company , ... client, which allows users to keep track of wines ... the right wine. At the center of WineMatch ... and wine information. All this information is assembled to ... that are close counterparts to one another are called ...
(Date:12/15/2014)... SUNDAY, Dec. 14, 2014 (HealthDay News) -- Expert pilots ... which explains why they make better decisions during landings, ... the most difficult techniques for pilots to master, and ... of fatal crashes occur during final approach and landing. ... pilots and 12 moderately experienced pilots while they were ...
(Date:12/15/2014)... 15, 2014 In support of ... attention to restrictive state laws that may have ... this important area of public health policy. , ... the Integrity of Independent Review, contends that state ... independent peer review determinations can result in subpar ...
Breaking Medicine News(10 mins):Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
... geared to genetic blueprints from Elite Books, TUCSON, Ariz., ... It,plays a key role in the development of Alzheimer,s Disease ... it is greatly affected,by diet. In her seminal book, ... Heart and Alzheimer,s Using the Body,s Own Genes,(Elite, Hardcover, $27.95, ...
... FRAMINGHAM, Mass., Nov. 5 StatSure Diagnostic,Systems, Inc. ... U.S.,Food and Drug Administration ("FDA"), through its Center ... under the Clinical Laboratory,Improvements Amendments of 1988 ("CLIA") ... patented "barrel" technology. The HIV 1/2 product,is marketed ...
... to place systems in more physician offices could ... of underserved patient populations, NEW YORK, Nov. 5 ... New York (HIP) will convene an educational seminar in,New ... treating,underserved patient populations. The seminar, to be held at ...
... Research Findings to Impact Human Health, Agricultural Science, ... Beauty announced that they successfully sequenced the complete ... fungus,responsible for the onset of dandruff and other ... are published in today,s online edition of,Proceedings of ...
... 5 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... Suisse Healthcare Conference will be webcast live and,may ... the Company,s website, http://www.millennium.com . (Logo: ... an overview of the Company, an update on,clinical ...
... to Compulsory Acquisition, WARSAW, Ind. and MONTREAL, Nov. ... ZMH), a leader in the orthopaedics,industry, and its indirect ... pursuant to the extension of the Offer,made for all ... a leader in computer navigation for orthopaedic,surgery, it has ...
Cached Medicine News:Health News:Groundbreaking Apo E Gene Diet Linked to Alzheimer's Disease and Heart Disease Prevention 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 3Health News:GHI and HIP Lead Effort to Expand Electronic Health Record System Throughout the City of New York 2Health News:Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders 2Health News:Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders 3Health News:2007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 2Health News:Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid 2Health News:Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid 3
3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
2 mm wide x 3 mm long, with rounded triangular tip. Angled 45 degrees. Hexagonal handle....
Duckbill type sharp. 3 mm wide x 8 mm long curved blade. Octagonal handle....
9 mm slightly curved blade. Hexagonal handle....
Medicine Products: